Abstract
We conducted a national, retrospective population-based cohort study of 705 patients hospitalized with a first diagnosis of dermatomyositis (DM) or polymyositis (PM) during 1982–1996 based on linkage of hospital discharge, cancer registration, and death records in Scotland. Risks of cancer were assessed by calculating standardized incidence ratios (SIR). A first malignancy was diagnosed concurrently or subsequently in 50 patients with DM (SIR 7.7, 95% CI 5.7–10.1), and 40 patients with PM (2.1, 1.5–2.9). Significantly elevated risks were observed for lung, cervix uteri, and ovarian cancer in patients with DM, and for Hodgkin's disease in patients with PM. The excess risk of cancer was highest around the time of diagnosis, and for patients with DM remained high for at least 2 years. Risks were elevated for both sexes but only significantly so for females, and were highest in patients aged 45–74 years at the time of diagnosis for DM and 15–44 for PM. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Airio A, Pukkala E and Isomäki H (1995) Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 22: 1300–1303
Brewster D, Crichton J and Muir C (1994) How accurate are Scottish cancer registration data?. Br J Cancer 70: 954–959
Brewster D, Crichton J, Harvey JC and Dawson G (1997) Completeness of case ascertainment in a Scottish Regional Cancer Registry. Public Health 111: 339–343
Chow WH, Gridley G, Mellemkjær L, McLaughlin JK, Olsen JH and Fraumeni JF Jr (1995) Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 6: 9–13
Harley K and Jones C (1996) Quality of Scottish Morbidity Record (SMR) data. Health Bulletin (Edinburgh) 54: 410–417
Hidano A, Torikai S, Uemura T and Shimizu S (1992) Malignancy and interstitial pneumonitis as fatal complications in dermatomyositis. J Dermatol 19: 153–160
Kendrick S and Clarke J (1993) The Scottish Record Linkage System. Health Bulletin (Edinburgh) 51: 72–79
Lakhanpal S, Bunch TW, Ilstrup DM and Melton LJ (1986) Polymyositis-dermatomyositis and malignant lesions: does an association exist?. Mayo Clin Proc 61: 645–653
Manchul LA, Jin A, Pritchard KI, Tenenbaum J, Boyd NF, Lee P, Germanson T and Gordon DA (1998) The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med 145: 1835–1839
Maos CR, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Bank I, Gur H and Ehrenfeld M (1998) High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Sem Arthrit Rheumat 27: 319–324
Rose C, Hatron PY, Brouillard M, Hachulla E, Gossett D, Marlier C, Piette F and Devulder B (1994) Predictive signs of cancers in dermatomyositis. Study of 29 cases. Rev Med Intern 15: 19–24
Selvaag E, Thune P and Austad J (1994) Dermatomyositis and cancer. A retrospective study. Tidsskrift Norke Laegeforening 114: 2378–2380
Sigurgeirsson B, Lindelöf B, Edhag O and Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. New Engl J Med 326: 363–367
Zantos D, Zhang Y and Felson D (1994) The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 21: 1855–1859
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Stockton, D., Doherty, V. & Brewster, D. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85, 41–45 (2001). https://doi.org/10.1054/bjoc.2001.1699
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1699
Keywords
This article is cited by
-
Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis
Clinical and Experimental Medicine (2024)
-
A meta-analysis of melanoma risk in idiopathic inflammatory myopathy patients
Zeitschrift für Rheumatologie (2024)
-
Clinical Characteristics of Dermatomyositis with Interstitial Lung Disease: A Retrospective Case–Control Study
Rheumatology and Therapy (2023)
-
Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports
Journal of Medical Case Reports (2022)
-
Idiopathic inflammatory myopathies
Nature Reviews Disease Primers (2021)